BrainStorm Cell Therapeutics
BCLI
#10415
Rank
โ‚ฌ5.27 M
Marketcap
0,48ย โ‚ฌ
Share price
-6.67%
Change (1 day)
-68.72%
Change (1 year)

Market capitalization of BrainStorm Cell Therapeutics (BCLI)

Market cap: โ‚ฌ5.27 Million

As of December 2025 BrainStorm Cell Therapeutics has a market cap of โ‚ฌ5.27 Million. This makes BrainStorm Cell Therapeutics the world's 10415th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of BrainStorm Cell Therapeutics from 2008 to 2025

End of year Market Cap

Year Marketcap Change
2025โ‚ฌ5.27 M-60.71%
2024โ‚ฌ13.42 M11.01%
2023โ‚ฌ12.09 M-78.35%
2022โ‚ฌ55.86 M-56.4%
2021โ‚ฌ0.12 B-0.94%
2020โ‚ฌ0.12 B46.09%
2019โ‚ฌ88.54 M37.45%
2018โ‚ฌ64.41 M4.64%
2017โ‚ฌ61.56 M36.41%
2016โ‚ฌ45.12 M-7.46%
2015โ‚ฌ48.76 M-18.47%
2014โ‚ฌ59.8 M160.33%
2013โ‚ฌ22.97 M-9.2%
2012โ‚ฌ25.3 M27.5%
2011โ‚ฌ19.84 M44.97%
2010โ‚ฌ13.68 M-1.15%
2009โ‚ฌ13.84 M484.09%
2008โ‚ฌ2.37 M

End of Day market cap according to different sources

On Dec 10th, 2025 the market cap of BrainStorm Cell Therapeutics was reported to be:

โ‚ฌ4.06 Million
by Nasdaq info icon info icon
โ‚ฌ5.27 Million
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Gilead Sciences
GILD
โ‚ฌ128.54 B 2,436,345.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
โ‚ฌ6.29 B 119,237.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Seagen
SGEN
โ‚ฌ36.84 B 698,256.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
โ‚ฌ22.23 B 421,408.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
โ‚ฌ0.11 B 2,150.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Acceleron Pharma
XLRN
โ‚ฌ9.33 B 176,801.78%๐Ÿ‡บ๐Ÿ‡ธ USA